Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Focus Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom
Trifluoperazine 5 mg/5 ml Oral Solution.
| Pharmaceutical Form |
|---|
|
Oral Solution. A clear, yellow coloured solution with characteristic orange odour. |
Each 5 ml of oral solution contains 5 mg trifluoperazine present as the hydrochloride.
Excipients with known effect: Each 1 ml of Trifluoperazine 5 mg/5 ml Oral Solution contains 0.86 mg sodium, 0.005 mg ethanol, 1 mg sodium benzoate, 100.95 mg propylene glycol and 0.0257 mg benzyl alcohol.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Trifluoperazine |
Trifluoperazine is one of the phenothiazine class of compounds and as such has many pharmacodynamic effects which relate to its therapeutic actions and side effects. The most notable action of phenothiazines is antagonism at dopamine receptors in the CNS. |
| List of Excipients |
|---|
|
Sodium benzoate |
Amber (Type III) glass bottle of 150 ml fill volume, with child-resistant, tamper-evident screw cap with an LDPE liner.
A 5 ml dosing syringe with intermediate graduations of 0.1 ml and a “press-in” syringe/bottle adaptor are provided. A 20 ml dosing cup with intermediate graduations is also provided with the product.
Focus Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom
PL 20046/0300
17/07/2018
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
